Clinical Trial Update: Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating myocardial protection in patients with post-acute inflammatory cardiac involvement due to COVID-19 is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Dysfunction
• Heart Failure
• Left Ventricular Dysfunction
• Microvascular Angina
• Myocarditis
• Pericarditis
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Valentina Puentmann | Conditions: COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle | Phase 3 | Status: ACTIVE_NOT_RECRUITING